Abstract Gastric cancer is one of the most commonplace and lethal cancers in the world. Molecular investigation of this disease, in order to obtain diagnostic and treatments achievements is important and vital. Relatively, in this research study, one of the most important epigenetic factors, the methylation of CDX2 gene was investigated in tumoral and non-tumoral tissues of gastric cancer patients by bisulfite treatment followed by sequencing of the 5'UTR region of CDX2 in both tissues. The results indicated a hypomethylation in tumoral tissues of adenocarcinoma. Consequently, the methylation amount of CDX2 in tumoral tissues was significantly reduced compared with non-tumoral tissues.
Introduction
Gastric cancer is the forth common kind of cancer globally and it is classified into intestinal and diffuse type (AkhavanNiaki and Samadani 2014; Nikbakhsh et al. 2016) . It is confirmed that gastric cancer is the result of epigenetic and genetic fluctuations in oncogenes, tumor suppressor genes, DNA miss match repair genes and regulators of cell cycle. In this account, DNA methylation represents one of the most important epigenetic factors. It can alter the activity of the DNA, specially leading to suppression or reduction of gene transcription. Correspondingly, DNA methylation is vital and indispensable for normal development and is related to many required functions including carcinogenesis, cell division and differentiation processes, X-chromosome inactivation and genomic imprinting (AkhavanNiaki and Samadani 2013; Calcagno et al. 2013) . Considerably, DNA methylation is divided into hyper and hypo methylation. In this way, hypermethylation usually happens at CpG islands in the promoter region and is directly related with gene function (Zhao and Bu 2012) . Aberrant DNA methylation models including hypermethylation and hypomethylation are related in the progression and development of all kinds of cancers including gastric cancer, by different mechanisms (Hur et al. 2011; Niwa et al. 2010; Shin et al. 2010; Wani et al. 2012) . In this account, aberrant methylation in CpG islands of tumor suppressor genes is a very impressive mechanism discovered in gastric cancer (Shi et al. 2012; Schneider et al. 2010) . Considerably, there are many genes that are involved in gastric cancer and have a conspicuous relationship with DNA methylation (Esteller et al. 2000; Samadani and Akhavan-Niaki 2015; Tycko 2010) . One of these genes is CDX2. It is a member of the caudal associated homeobox transcription factor gene family. This gene has many roles particularly in differentiation and cell growth Camilo et al. 2012) . It also plays a key role in early embryonic development of the intestinal tract. Aberrant expression of this gene is directly related with tumorigenesis and intestinal inflammation and disorders in digestive system (Qin et al. 2012; Rugge et al. 2004) . Conclusively, researches on molecular mechanisms of these epigenetic factors can lead to novel achievements especially in diagnosis and treatment. The aim of this study was the discovery of molecular fluctuations of CDX2 methylation in gastric tumors.
Material and methods

Samples collection
The samples were gathered from patients who had gastric cancer with adenocarcinoma tissues (stages 1 to 4 and ages between 36 to 89 years, male and female) after gaining patients relative's agreement from hospitals of Babol city in Iran. Relatively, the tumoral and non-tumoral (normal) tissues were provided from surgery room for each patient. For confirmation of the kind of the tissues, all specimens were controlled with pathological reports. Eventually, tissue samples were stored at −80°C for further analyzes.
DNA extraction
DNA preparation was accomplished with DNA extraction Kit (Bioneer -Accu plep, South Korea) according to the manufacturer's instructions. The evaluation of quantity and quality of extracted DNA was performed by agarose gel electrophoresis and spectrophotemetric measurement (NanoDrop® ND-1000, Thermo Fisher Scientific, USA) at 260 nm.
DNA methylation evaluation
For investigation of DNA methylation, initially, bioinformatics software (Meth primer) was recruited to find GC rich regions of CDX2 gene. Specific primers (Forward: 5'GCCATYTTTTAAAATGYAAATTATGTTT3', Reverse: 5'AAACCTCACCATRCTRCCT3') were designed for amplification of 5'UTR region of CDX2 gene by PCR method. The methylation kit (Zymoresearch, EZ DNA methylationGold TM kit, USA) was used according to the manufacturer's instruction for bisulfite conversion of 20 μl genomic DNA. (15-30 ng/μl). 3-4 μl bisulfite treated genomic DNA was amplified in a 25 μl final volume using forward and reverse primers by initial incubation at 95°C for 5 min, followed by 40 cycles of 95°C for 30 s and 57°C for 50 s and 72°C for 50 s and a final extension at 72°C for 14 min. Relatively, for investigation of methylation pattern of amplicons, confirmation and identifying of different methylated nucleotides, all PCR products were sequenced in a ABI set (Bionneer, South Korea). The acquired sequencing data were analyzed in tumoral and non-tumoral tissues by QUMA (QUantification tool for Methylation Analysis)a web-based bisulfite sequencing analysis tool for CpG methylation analysis available at http://quma.cdb.riken.jp/.
Statistical analysis
Data were analyzed using the ANOVAs test and SPSS software. P value <0.05 was considered as statistically significant.
Results
The sequence of CDX2 gene spanning from nucleotide −39 to + 291 (NCBI code: accession, EU544225) show all investigated CpG sites (Fig. 1) . The methylation situation of the 27 CpG sites of 5'UTR of CDX2 gene in tumoral (Fig. 2) and non-tumoral (Fig. 3) 
Discussion
Gastric cancer is a serious disease which is driven by progressive genetic and epigenetic origination. The key role of DNA methylation in the pathogenesis of gastric cancer is proven and remarkable. This epigenetic modification collaborates also with gene mutations in the development of normal gastric mucosa. Remarkably, these modifications in DNA methylation help to the molecular heterogeneity changes of gastric cancer. Calculating and counting the amount of methylated and unmethylated parts of DNA is of particular importance on the diagnosis and prevention in all kinds of cancers especially in gastric one. Obviously, it is confirmed that the section of active DNA demethylation depends on the function of the cell programming (19). Relatively, previous studies and searches indicated that CDX2 gene had transcriptional function in CDX2-expressing gastric cancer (Camilo et al. 2014 ). Correspondingly, it was shown that the expression of CDX2 was silenced by unknown repressing pathway(s) other than DNA methylation. At least two CpG islands exist in the promoter and 5'UTR of the CDX2 gene, with the methylation status of the lower site being related with expression of CDX2 (Kang et al. 2011) . In this way, the alterations of CDX2 gene in tumoral and non tumoral tissues had different effect and the situation of promoter is involved in this process. Conspicuously, in the present study, the tumoral and non-tumoral tissues indicated to have both methylated and unmethylated modifications of CDX2 in gastric cancer patients. It is confirmed that the methylation is not a dominant process in carcinogenesis (Ebrahimi-Askari et al. 2015) . In a comparison of methylation fluctuation between P15 gene in esophagus cancer and CDX2 in our research, other mechanisms like loss of heterozygosity (LOH) can have a more important role in inactivation of these genes (Rotkrua et al. 2011) . Transparently, the amount of methylation of P15 gene in tumoral tissues was 16.6% and it is approved that the methyation has not a significant correlation in esophagus cancer (Rotkrua et al. 2011) . Similarly, the methylation amount of CDX2 was different and some sections became methylated in tumoral in comparison to non-tumoral tissues. The amount of P value of CpG sites number 3 and 20 of the 5'UTR was 0.04 and 0.00047, respectively. Thus the present data strongly suggest methylation fluctuations of CDX2 in tumoral tissues of adenocarcinoma. Therfore, the methylation amount of CDX2 in tumoral tissues is significantly reduced compared to non-tumoral tissues.
Conclusively, investigating the molecular mechanisms of cancer development and identifying critical regions exposed to methylation fluctuations will permit a better understanding of the role of epigenetic modifications in all types of cancer particularly in gastric cancer and will lead to therapeutic and preventive approaches. Fig. 4 Representative electrophoregrams of CDX2 methylation pattern.
These electrophoregrams represent the sequence of nucleotides +175 to +291 of CDX2 corresponding to (a): a non-tumoral tissue and (b): a tumoral tissue examined after bisulfite conversion of genomic DNA and sequencing. All cytosines are converted to thymine while methylated cytosines remain unchanged and are read as cytosine. Red arrow indicates unmethylated CpG and blue arrow indicates methylated CpG
